Does LEVETIRACETAM Cause Malignant neoplasm progression? 62 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 62 reports of Malignant neoplasm progression have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.1% of all adverse event reports for LEVETIRACETAM.
62
Reports of Malignant neoplasm progression with LEVETIRACETAM
0.1%
of all LEVETIRACETAM reports
21
Deaths
35
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LEVETIRACETAM?
Of the 62 reports, 21 (33.9%) resulted in death, 35 (56.5%) required hospitalization, and 9 (14.5%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 62 reports have been filed with the FAERS database.
What Other Side Effects Does LEVETIRACETAM Cause?
Seizure (9,961)
Drug ineffective (8,666)
Off label use (5,789)
Maternal exposure during pregnancy (3,197)
Foetal exposure during pregnancy (2,604)
Epilepsy (2,546)
Generalised tonic-clonic seizure (2,276)
Somnolence (2,070)
Fatigue (1,972)
Status epilepticus (1,883)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LEVETIRACETAM Alternatives Have Lower Malignant neoplasm progression Risk?
LEVETIRACETAM vs LEVOBUNOLOL
LEVETIRACETAM vs LEVOBUPIVACAINE
LEVETIRACETAM vs LEVOCARNITINE
LEVETIRACETAM vs LEVOCETIRIZINE
LEVETIRACETAM vs LEVODOPA